New Brighton, MN, United States of America

He Huang

This inventor holds 2 USPTO granted patents. Top assignee: Parker Hughes Institute. Active years: 2002-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: He Huang. Retrieved from https://idiyas.com/inventor/he-huang-qbd999er

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2002-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: He Huang: A Pioneer in Anti-Cancer Innovations

Introduction

He Huang, a prominent inventor based in New Brighton, MN, has made significant strides in the field of cancer research through his innovative work. With two patents to his name, he has dedicated his efforts to developing novel compounds aimed at combating cancer and improving treatment outcomes.

Latest Patents

Huang's latest patents focus on creating synthetic spiroketal pyranes as potent anti-cancer agents. These include novel tubulin binding compounds, known as SPIKETS, which exhibit powerful tubulin depolymerization activity and inhibitory effects on tubulin polymerization. This groundbreaking research showcases the efficacy of these compounds as agents for inhibiting cellular proliferation, particularly in cancer cells. The compounds are engineered to interact favorably with a newly discovered SP binding pocket on tubulin, opening pathways for the screening of anti-tubulin, anti-proliferation, and anti-cancer pharmaceuticals.

Career Highlights

He Huang contributes his expertise at Parker Hughes Institute, where he engages in cutting-edge research aimed at combating cancer. His patents reflect a deep understanding of molecular interactions and a commitment to advancing therapeutic options for patients in need. Huang's innovative work is protecting through two active patents, contributing to the growing body of knowledge in cancer therapeutics.

Collaborations

Throughout his career, Huang has collaborated with notable individuals in the field, including Chen Mao and Faith M Uckun. Together, they contribute to research initiatives that prioritize the discovery and development of new treatments, reflecting a shared commitment to improving cancer care.

Conclusion

He Huang stands at the forefront of anti-cancer innovation, demonstrating a remarkable ability to blend scientific research with practical applications in therapeutic development. His contributions not only underscore the importance of innovation in the fight against cancer but also highlight the significance of collaboration in achieving groundbreaking results. As the landscape of cancer treatment continues to evolve, Huang's work promises to make a lasting impact on patients and the medical community alike.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…